Connect with us

Stock News

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Published

on


Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease drug that the company developed with Japanese partner Eisai — reversing an earlier decision not to approve the drug.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock News

Palantir’s stock is moving to the Nasdaq. Why investors are cheering the move.

Published

on


The change positions Palantir for entry into the Nasdaq 100 index, after it joined the S&P 500 several months back.

Continue Reading

Stock News

‘I’m 38 and completely broke’: I earn $50,000 a year. What professional degree will guarantee me six figures?

Published

on


“I am willing to put in an extra 1 to 4 years of schooling and use student loans to pay for it.”

Continue Reading

Stock News

These tips for investing in mutual funds and ETFs keep your portfolio plugged in

Published

on


Portfolio changes, small-caps are a big deal, and investors pile into ETFs.

Continue Reading

Trending